Nutriband Inc.

NASDAQ:NTRB

5.81 (USD) • At close November 4, 2024
Bedrijfsnaam Nutriband Inc.
Symbool NTRB
Munteenheid USD
Prijs 5.81
Beurswaarde 64,527,022
Dividendpercentage 0%
52-weken bereik 1.927 - 9.595
Industrie Biotechnology
Sector Healthcare
CEO Mr. Gareth Sheridan
Website https://nutriband.com

An error occurred while fetching data.

Over Nutriband Inc.

Nutriband Inc. develops a portfolio of transdermal pharmaceutical products. The company's lead product in development is AVERSA fentanyl, an abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain requiring around the clock opioid therapy. It also develops

Vergelijkbare Aandelen

Corbus Pharmaceuticals Holdings, Inc. logo

Corbus Pharmaceuticals Holdings, Inc.

CRBP

18.31 USD

Oncternal Therapeutics, Inc. logo

Oncternal Therapeutics, Inc.

ONCT

1.48 USD

X4 Pharmaceuticals, Inc. logo

X4 Pharmaceuticals, Inc.

XFOR

0.532 USD

Biomerica, Inc. logo

Biomerica, Inc.

BMRA

0.355 USD

Terns Pharmaceuticals, Inc. logo

Terns Pharmaceuticals, Inc.

TERN

7.1 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)